CCN2 and Hepatic fibrosis: In vivo experiments showed that the severity of hepatic fibrosis in a CCl4-induced rat liver fibrosis model was negatively correlated with the promoter methylation level of the CTGF in HSCs, suggesting that promoter methylation of the CTGF may prevent the occurrence of hepatic fibrosis.